Brazil COVID-19 vaccine trial continues after volunteer dies

Brazil’s National Health Surveillance Agency (ANVISA) said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died, but said the trial would continue. It was not immediately clear whether the volunteer received the vaccine or the placebo.